Electrophysiology Mapping and Ablation Devices | Market Insights | Europe (Supplemental) | 2025
The European EP mapping and ablation device market will experience strong growth through 2033, driven
by the increasing prevalence of cardiac arrhythmia in Europe, improved access to treatment, advancements
in ablation and diagnostic technologies, favorable clinical guidelines supporting cardiac ablation, and
clinical evidence supporting the uptake of premium-priced devices.